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Structural basis for LAR-RPTP/Slitrk
complex-mediated synaptic adhesion
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Synaptic adhesion molecules orchestrate synaptogenesis. The presynaptic leukocyte
common antigen-related receptor protein tyrosine phosphatases (LAR-RPTPs) regulate
synapse development by interacting with postsynaptic Slit- and Trk-like family proteins
(Slitrks), which harbour two extracellular leucine-rich repeats (LRR1 and LRR2). Here we
identify the minimal regions of the LAR-RPTPs and Slitrks, LAR-RPTPs Ig1–3 and Slitrks LRR1,
for their interaction and synaptogenic function. Subsequent crystallographic and structure-
guided functional analyses reveal that the splicing inserts in LAR-RPTPs are key molecular
determinants for Slitrk binding and synapse formation. Moreover, structural comparison of
the two Slitrk1 LRRs reveal that unique properties on the concave surface of Slitrk1 LRR1
render its speciﬁc binding to LAR-RPTPs. Finally, we demonstrate that lateral interactions
between adjacent trans-synaptic LAR-RPTPs/Slitrks complexes observed in crystal lattices
are critical for Slitrk1-induced lateral assembly and synaptogenic activity. Thus, we propose a
model in which Slitrks mediate synaptogenic functions through direct binding to LAR-RPTPs
and the subsequent lateral assembly of LAR-RPTPs/Slitrks complexes.
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N
euronal communication occurs at specialized asymme-
trical junctions termed synapses. Synaptogenesis, which is
the formation of a fully functional synapse, proceeds
via a series of neuronal process that include the initial axon–
dendrite contact, synapse formation and synapse maturation.
Synaptic adhesion molecules located in the pre- and postsynaptic
membranes play key roles in synaptogenesis. Similar to other
cellular adhesion molecules (for example, those in tight junctions
and immunological synapses), synaptic adhesion molecules
physically align two neuronal cells and orchestrate the necessary
bidirectional neuronal signalling pathways by forming trans-
synaptic adhesion complexes1.
The leukocyte common antigen-related receptor protein
tyrosine phosphatases (LAR-RPTPs), which are classiﬁed as type
IIa RPTPs, have recently emerged as a major family of synaptic
adhesion molecules that also play crucial roles in neurite
outgrowth, axon guidance and central nervous system (CNS)
regeneration2,3. The vertebrate LAR-RPTP family has three
members, LAR, PTPd and PTPs; their extracellular regions
contain three immunoglobulin-like (Ig) domains and four to
eight ﬁbronectin III (FNIII) repeats (determined by alternative
splicing). In particular, multiple LAR-RPTP isoforms are
generated by alternative splicing of four mini exons, termed
MeA to MeD, that encode short peptides (Fig. 1a)4,5. The LAR-
RPTPs have a single transmembrane domain followed by two
intracellular phosphatase domains (a membrane-proximal
catalytic domain called D1 and a membrane-distal non-catalytic
domain called D2) where multiple intracellular adaptor proteins
bind6. Recently, a growing number of postsynaptic adhesion
molecules have been identiﬁed as adhesion partners of the
LAR-RPTPs; these include NGL-3 (netrin-G ligand 3), TrkC
(neurotrophin receptor tyrosine kinase C), IL-1RAcP (interleukin
1 receptor accessory protein), IL1RAPL1 (IL-1 receptor accessory
protein-like 1) and the Slitrks (Slit- and Trk-like family
proteins)2,3. Two alternative splicing sites within the Ig domain
of the LAR-RPTPs (MeA and MeB) have received particular
attention, because they modulate the interactions with various
postsynaptic ligands, such as TrkC, IL-1RAcP and IL1RAPL1
(refs 7–9).
Among the LAR-RPTP ligands, the Slitrks were recently shown
to induce presynaptic differentiation10,11. The six members of the
Slitrk family (Slitrk1–6) are neuron-speciﬁc transmembrane
proteins that localize at the postsynaptic membrane and exhibit
domain structures similar to those of the classic axon guidance
molecule, Slit12. All six Slitrks possess two leucine-rich repeat
(LRR) domains in their extracellular regions; called LRR1 and
LRR2, these domains are connected by a 70–90 amino acid loop.
Each LRR domain has six LRR modules ﬂanked by cysteine-rich
regions at its amino terminus (LRRNT) and carboxy terminus
(LRRCT)12. The Slitrk family members exhibit synaptogenic
activities through their interactions with speciﬁc LAR-RPTP
members10. Speciﬁcally, Slitrk1, Slitrk2, Slitrk4 and Slitrk5
promote excitatory synapse formation by interacting with PTPs,
whereas Slitrk3 enhances inhibitory synapse formation by
interacting with PTPd10. However, the lack of a high-resolution
structure of the LAR-RPTP/Slitrk complex has limited our
understanding of how these proteins act in synapse formation.
Developing a greater understanding of the detailed molecular
mechanisms underlying the functions of trans-synaptic adhesion
pathways will be crucial for the future development of therapeutic
strategies against a range of neurological disorders in which Slitrks
and LAR-RPTPs have been implicated, including autism spectrum
disorders, attention-deﬁcit hyperactivity disorders, Tourette’s
syndrome, trichotillomania and epilepsy2,3,13.
Here we identiﬁed the minimal binding regions of the LAR-
RPTPs and Slitrks, and determined the crystal structure of the
resulting complex (PTPd Ig1–3/Slitrk1 LRR1). We then per-
formed an extensive functional analysis based on this complex
structure and gained important insights into the molecular
mechanism and the physiological signiﬁcance of interactions
between LAR-RPTPs and Slitrks in synaptogenesis. Our struc-
tural analysis of Slitrk1 LRR2 provided novel insights into how
LAR-RPTPs speciﬁcally bind to Slitrk1 LRR1 but not Slitrk1
LRR2. Finally, from the crystal-packing lattices, we identiﬁed
adjacent interactions between the convex surface of Slitrk LRR1
and the neighbouring PTPd Ig1–3, and found that these lateral
interactions are essential for Slitrk1-mediated surface cluster
formation and presynaptic differentiation. These data suggest a
model of the trans-adhesion complex wherein LAR-RPTPs and
Slitrks coordinate synaptogenesis in a two-step process: direct
binding of postsynaptic Slitrks to presynaptic LAR-RPTPs and
subsequent lateral assembly in the formed complexes.
Results
Minimal domain identiﬁcation for binding and synaptogenesis.
Our group and others recently demonstrated that LAR-RPTPs
interact with Slitrks, and that this interaction contributes to reg-
ulating synapse formation and function10,11. To further
characterize this interaction at the molecular level, we focused on
PTPs and Slitrk1, a trans-synaptic adhesion molecule pair that was
shown to speciﬁcally promote excitatory synapse development10.
We ﬁrst generated three pDis-PTPs constructs containing
different extracellular domains: the full extracellular region
(PTPs Full), the three Ig domains alone (PTPs Ig1–3) and the
eight FNIII repeats alone (PTPs FN1–8) (Supplementary Table 1;
see the architectures of LAR-RPTPs and Slitrks in Fig. 1a). We then
performed cell-adhesion assays with L cells expressing various
PTPs variants and the full extracellular region of Slitrk1 (Slitrk1
Full) (Fig. 1c,d). Consistent with our previous observation that
LAR-RPTPs mediate the trans-interaction with Slitrks10, L cells
expressing PTPs full strongly aggregated with L cells expressing
Slitrk1. The extent of aggregation among cells expressing PTPs
Ig1–3 was similar to that observed with PTPs Full, indicating that
PTPs Ig1–3 is sufﬁcient for Slitrk1 binding (Fig. 1c,d). PTPd Ig1–3
also bound to Slitrk1 (Supplementary Fig. 1). NGL-3 bound to the
FNIII repeats but not to Ig1–3, which is consistent with a previous
report that NGL-3 binds to the ﬁrst two FNIII repeats of LAR-
RPTPs14.
The Slitrks contain two clusters of LRR modules, termed LRR1
and LRR2 (ref. 12) (Fig. 1a). We thus generated two additional
pDis-Slitrk1 constructs containing LRR1 alone (Slitrk1 LRR1) or
LRR2 alone (Slitrk1 LRR2), and performed cell-adhesion assays
(Fig. 1e,f). L cells expressing Slitrk1 Full or Slitrk1 LRR1, but not
Slitrk1 LRR2, strongly aggregated with L cells expressing PTPs
Ig1–3, indicating that Slitrk1 LRR1 mediates PTPs binding
(Fig. 1e,f). Consistent with the results from the cell-adhesion
assays, recombinant PTPs Ig1–3 or PTPd Ig1–3 proteins
speciﬁcally interacted with recombinant Slitrk1 Full or Slitrk1
LRR1, but not with Slitrk1 LRR2 (Fig. 1b and Supplementary
Fig. 1c,d). In addition, the respective LRR1 domains of Slitrk2 and
Slitrk3 also mediated interactions with PTPs in cell-adhesion
assays (Supplementary Fig. 2a,b). Collectively, these results
indicate that Ig1–3 of the LAR-RPTPs and LRR1 of the Slitrks
are sufﬁcient for their mutual interactions.
We next tested whether Slitrks LRR1 is sufﬁcient to induce
presynaptic differentiation. Heterologous synapse-formation
assays showed that Slitrk1 LRR1, but not Slitrk1 LRR2, induced
the clustering of the presynaptic vesicle protein, synapsin, in
contacting axons of co-cultured neurons to an extent similar to
that induced by Slitrk1 Full (Fig. 1g,h). Extending these
heterologous synapse-formation assays to other Slitrks, we also
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found that the LRR1 domains of the other Slitrks were sufﬁcient
to induce presynaptic differentiation at a level similar to that
triggered by their full-length extracellular counterparts
(Supplementary Fig. 2c,d). Taken together, these results indicate
that Slitrks orchestrate presynapse development through direct
interactions with LAR-RPTPs, and that these interactions are
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Figure 1 | Determination of minimal binding domains of PTPr and Slitrk1. (a) Schematic domain structures of LAR-RPTPs and Slitrk family members.
Abbreviations: Ig, Ig-like domain (Ig1, red; Ig2, yellow; and Ig3, green); F, ﬁbronectin-like domain (grey); D1 and D2, phosphatase domains; N, N termini; C, C
termini; LRR, leucine-rich repeat. The LRR1 and LRR2 domains of Slitrk1 are shown in dark blue and light blue, respectively. The relative positions of the
MeA, MeB, MeC and MeD splice inserts are indicated by arrow head. Minimal binding domains are indicated with red lines. (b) Analysis of the interaction
between PTPs and Slitrk1 by pull-down assays. Recombinant Slitrk1 LRR1-Fc (B52 kDa), Slitrk1 LRR2-Fc (B52 kDa) or Slitrk1Full-Fc (B87 kDa) were
immobilized using protein A-Sepharose, followed by incubation with PTPs Ig1–3 (B33 kDa). Bound proteins were analysed by Coomassie Blue staining.
(c–f) Representative images (c,e) and summary bar graphs (d,f) from our cell-adhesion assays. One group of L cells co-expressing DsRed and the indicated
PTPs variants was mixed with a second group of L cells co-expressing EGFP and indicated Slitrk1 variants. The dark grey bars are signiﬁcantly different
from the control, whereas the light grey bars are not signiﬁcantly different at Po0.05. ‘n’ denotes the total number of cell aggregates from three
independent experiments (200–1,000 aggregates from 5 to 9 cells); statistical signiﬁcance in d and f was assessed using analysis of variance (ANOVA)
with Tukey’s test (3*Po0.001). Error bars in d and f represent s.d from three replicates. Scale bar, 100mm. (g,h) Heterologous synapse-formation assays.
HEK 293T cells transfected with EGFP alone (Control) or the indicated Slitrk1 variants were cocultured with hippocampal neurons and examined by
double immunoﬂuorescence using antibodies against GFP/HA (green) and synapsin (red). Representative images are shown (g), and the normalized
synapse density is expressed as the ratio of synapsin staining to GFP/HA ﬂuorescence (h). Results are expressed as means±s.d. (error bars) of three (n)
independent experiments; statistical signiﬁcance in (h) was assessed using ANOVA with Tukey’s test (3*Po0.001). Scale bar, 30mm.
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mediated by their minimal binding regions, LAR-RPTPs Ig1–3
and Slitrk LRR1.
Structure of minimal binding complex PTPd Ig1–3/Slitrk1 LRR1.
We initially sought to crystallize the physiological synaptic
adhesion complex (PTPs Ig1–3/Slitrk1 LRR1), but these attempts
failed to yield complex crystals. Thus, to examine the atomic
details of the interaction between LAR-RPTPs and Slitrks, we
crystallized the PTPd Ig1–3/Slitrk1 LRR1 complex and deter-
mined its structure at a resolution of 3.06Å (Table 1). Our ana-
lysis of the crystal structure of the PTPd Ig1–3/Slitrk1 LRR1
complex revealed that PTPd Ig1–3 binds to Slitrk1 LRR1 with a
1:1 stoichiometry, and the Ig2–3 domains of PTPd contribute to
this interaction (Fig. 2a and Supplementary Fig. 3a). Of the two
splicing inserts of PTPd Ig1–3 (MeA and MeB), only MeB was
found to participate in the interaction with Slitrk1 (see below).
Slitrk1 LRR1, which has the typical horseshoe shape of an LRR
domain15, contains eight-stranded parallel b-sheets on the
concave surface where PTPd predominantly binds and variable
loops on its convex surface.
The binding interface could be divided into three distinct
regions termed the A, B and C patches (Fig. 2a). Their buried
surface areas were 741, 535 and 497Å2, respectively, and all
residues involved in the interactions of each patch are presented
in Fig. 2b,c. The A patch is formed by the A0-G/G0-F-C b-sheet of
the PTPd Ig2 domain and the upper parts of the b3Bb5 strand
on the concave surface of Slitrk1 LRR1. In the A patch, multiple
electrostatic interactions are mediated by residues of the PTPd Ig2
domain (K135, Q202, N222 and Y224) and Slitrk1 LRR1 (R110,
E133, E157 and E206), which surround the network of
hydrophobic core interactions (Fig. 2b,c). The B patch interac-
tion, which occurs between the Ig2-MeB splice inserts of PTPd
and the lower parts of the b4Bb6 strand on the concave surface
of Slitrk1 LRR1, is mainly mediated by ionic interactions and
hydrogen bonds. In particular, two positively charged arginine
residues of PTPd (R226 in Ig2 bG0 and R229 in MeB) bind
respectively to two negatively charged arginine pockets in Slitrk1
LRR1 (Arg pockets 1 and 2). Arg pocket 1 is composed of Q136,
D138, N162 and D183, while Arg pocket 2 is composed of D163,
G186, E210 and D211 (Fig. 2b and Supplementary Fig. 3b). The C
patch contains two hydrogen bonds, S239 and R286, in the Ig3
domain of PTPd, which bind the side-chain amide and backbone
carbonyl of Q248, respectively, in the LRRCT of Slitrk1 LRR1.
The C patch interaction probably contributes to holding the
PTPd Ig3 domain in a rigid arrangement, preventing it from
swinging around on the ﬂexible loop located between Ig2 and Ig3
of PTPd. A conservation analysis was performed on the sequences
listed in Supplementary Table 2, using the Consurf server16. It
showed that in the A, B and C patches, the key residues involved
in the interaction are highly conserved with the exception of E157
and Q248 of Slitrk1 (Fig. 2d and Supplementary Fig. 4).
Critical residues for presynaptic differentiation. The overall
structures of Ig1–2 of PTPd and PTPs are almost identical17. Our
in vitro biochemical and cell biological experiments also showed
that both PTPd Ig1–3 and PTPs Ig1–3 bind equally well to Slitrk1
LRR1 (Fig. 1 and Supplementary Figs 1 and 2). Moreover,
additional analyses revealed that the PTPd residues involved in the
interaction with Slitrk1 were exactly identical to the corresponding
critical residues of PTPs (Supplementary Fig. 4). Thus, we
hypothesized that the mode through which PTPs Ig1–3 binds to
Slitrk1 LRR1 should be analogous to that of PTPd Ig1–3. On the
basis of this assumption, and guided by the structural information
obtained from the PTPd Ig1–3/Slitrk1 LRR1 complex, we designed
a series of PTPs and Slitrk1 mutations that we predicted to
abolish mutual binding or alter the binding interfaces, presumably
changing their respective binding properties (Fig. 3a).
To examine the signiﬁcance of each interaction patch in
PTPs, we introduced the following speciﬁc point mutations in
pDis-PTPs Ig1–3 (Supplementary Table 3): Y233S, which was
intended to disrupt hydrophobic interactions in the A patch;
R235A, R238A and R235D/R238D, which were intended to
disrupt complementary charge interactions in the B patch; and
S248A and R295A, which were intended to disrupt the two
hydrogen bonds in the C patch. We expressed PTPs Ig1–3 wild-
type (WT) and each PTPs Ig1–3 mutant on the surface of
HEK293T cells and used cell surface-binding assays to measure
the binding of recombinant Slitrk1-Fc WT proteins to these
PTPs variants (Fig. 3b). All of the mutants were defective for
Slitrk1 binding, except for two (PTPs Ig1–3 S248A and PTPs
Ig1–3 S248A/R295A) (see Supplementary Fig. 5e for binding-
afﬁnity data). We obtained consistent results from additional cell-
adhesion assays (Supplementary Fig. 5a,c). We also designed a
series of Slitrk1 mutants to disrupt the binding to PTPs Ig1–3
and generated recombinant Slitrk1-Fc proteins (WT and various
point mutants in Slitrk1; Fig. 3c). We then performed cell surface-
binding assays with HEK293T cells expressing PTPs Ig1–3 WT.
We found that all of the tested mutants abolished the binding of
PTPs Ig1–3, with the exception of two point mutants in
Slitrk1: E157A in the A patch and Q248A in the C patch (Fig. 3c).
Similar results were obtained from cell-adhesion assays
Table 1 | Data collection and reﬁnement statistics.
PTPd Ig1–3/Slitrk1
LRR1 (MeAþ ,
MeBþ )
Slitrk1 LRR2
Data collection
Space group P21 P6122
Cell dimensions
a, b, c (Å) 77.28, 60.37, 84.14 69.61, 69.61, 409.95
a, b, g () 90.00, 102.14, 90.00 90.00, 90.00, 120.00
Resolution (Å) 50.00–3.00
(3.05–3.00)
50.00–3.20
(3.26–3.20)
Rsym or Rmerge 0.146 (0.458) 0.112 (0.527)
I/sI 14.1 (2.6) 35.0 (3.4)
Completeness (%) 98.6 (95.9) 99.0 (100.0)
Redundancy 4.4 (3.2) 12.6 (9.6)
Wilson B-factor 59.2 107.0
Reﬁnement
Resolution (Å) 38.64–3.00 48.57–3.20
No. reﬂections/test
set
14,347/758 10,565/1,044
Rwork/Rfree 25.23/27.82 23.21/28.76
No. atoms
Protein 4,239 3,720
Ligand (sugar)/ion 42/1 —
Water 2 3
B-factors
Protein 75.54 96.55
Ligand/ion 102.02/112.83 —
Water 29.74 43.27
Root mean squared deviations
Bond lengths (Å) 0.013 0.003
Bond angles () 1.3 0.652
Values in parentheses are for highest-resolution shell.
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performed with L cells expressing PTPs Ig1–3 and the Slitrk1
variants (Supplementary Fig. 5b,d; see also Supplementary Fig. 5e
for binding-afﬁnity data). These ﬁndings collectively suggest that
highly conserved residues in the A and B patches are required for
this interaction.
Slitrks have been shown to potently induce presynaptic
differentiation in heterologous synapse-formation assays10,11.
Intriguingly, Slitrk1 triggers presynaptic differentiation at both
excitatory and inhibitory synapses and requires distinct LAR-
RPTP isoforms for the speciﬁcation of distinct synapse types10.
Thus, we examined whether Slitrk1 point mutants defective
in LAR-RPTP binding activity could induce presynaptic
differentiation in heterologous synapse-formation assays. The
expression level of each Slitrk1 point mutant (constructed in a
pCMV5-Slitrk1-mVenus backbone) was quantiﬁed based on the
mVenus moiety and the amount of synapse formation by
transfected HEK293T cells was assessed using indirect
immunoﬂuorescent detection of the presynaptic marker
proteins, VGLUT1 (vesicular glutamate transporter 1, an
excitatory presynaptic marker) and VGAT (vesicular GABA
transporter, an inhibitory presynaptic marker) (Fig. 3d–f).
Consistent with our cell surface-binding and cell-adhesion
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Figure 3 | Critical residues for PTPr/Slitrk1 binding and synaptogenic activity. (a) An open-book view showing the interacting interfaces of the PTPd
Ig1–3/Slitrk1 LRR1 complex. The orientations of PTPd and Slitrk1 are identical to those in Fig. 2d. The amino acid residues mutated for our functional
analyses are labelled and shown in orange; the residue numbers of PTPs are shown in parentheses. (b) Cell surface binding assays performed with
HEK293T cells expressing PTPs Ig1–3 WT or its various mutants. Cells were analysed by immunoﬂuorescence imaging for Slitrk1 LRR1-Fc (red) and
HA-tagged PTPs Ig1–3 (green). Scale bar, 20mm. (c) Cell surface binding assays were performed as described in b, except that the HEK293T cells
expressing PTPs Ig1–3 WT were incubated with Fc or the indicated Slitrk1 LRR1-Fc variants. Scale bar, 20mm. (d–f) Representative immunoﬂuorescence
images (d,e) and summary bar graphs (f) for our heterologous synapse-formation assays. Hippocampal cultured neurons were cocultured with HEK293T
cells expressing mVenus alone (Control), Slitrk1 WT fused with mVenus (Slitrk1 WT), or various Slitrk1 mutants fused with mVenus (Y134R, Y134W, E157A,
I160W, N162R, D163R/D211R or Q248A) and stained with antibodies against EGFP (green) and excitatory (VGLUT1; d) or inhibitory (VGAT; e) presynaptic
markers (red). Results are expressed as means±s.d. (error bars) of three (n) independent experiments; statistical signiﬁcance in f was assessed
using analysis of variance (ANOVA) with Tukey’s test. Darker grey bars are signiﬁcantly different from control (3*Po0.001). (g) Rat hippocampal neurons
were transfected with GFP (Control), Slitrk1 WT or Slitrk N162R, and stained for the synaptic maker, synapsin (red) and EGFP (green). Scale bar, 5 mm.
(h) Quantiﬁcation of the synaptic density shown in g. Results are expressed as means±s.d. (error bars) of three (n) independent experiments; statistical
signiﬁcance in h was assessed using ANOVA with Tukey’s test (3*Po0.001).
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assays, all Slitrk1 mutants that lacked PTPs binding were unable
to induce synapse formation (Fig. 3d–f). Biotinylation assays and
indirect immunoﬂuorescence assays showed that all of the Slitrk1
mutants were well expressed at the cell surface, except for Slitrk1-
I160W and Slitrk1-D163R/D211R (Supplementary Fig. 6a,b). To
overcome the poor surface transport of some Slitrk1 mutants, we
expressed the Slitrk1 variants (pDis-HA-Slitrk1) at the cell surface
of HEK293T cells and conducted heterologous synapse-formation
assays. All of the Slitrk1 mutants failed to induce synapse
formation, with the exception of Slitrk1-Q248A (Supplementary
Fig. 6c,d).
Next, we transfected rat hippocampal neurons with vectors
encoding enhance green ﬂuorescence protein (EGFP) alone
(Control), mVenus-fused WT and EGFP (Slitrk1 WT), or
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Figure 4 | Splicing inserts MeB of LAR-RPTPs modulates Slitrks binding. (a) Structural comparison of LAR-RPTPs in the presence and absence
of MeB splicing inserts (left) and close-up view of arginine pockets on Slitrk1 LRR1 (right). The colour coding of PTPd Ig1–3 (MeAþ , MeBþ ) is as
described in Fig. 2a, and the structure of PTPs Ig1–3 lacking MeA and MeB (2YD9) is shown in grey. Compared with the Ig3 domain of PTPs Ig1–3 (MeA-,
MeB-), the Ig3 domain in the PTPd Ig1–3 (MeAþ , MeBþ ) was rotated by 62 around V225, which is the last residue of the second Ig2 domain in PTPd.
(b) HEK293Tcells expressing the indicated splice variants of PTPs Ig1–3 were incubated with Slitrk1 LRR-Fc and analysed by immunoﬂuorescence for Slitrk1
LRR1-Fc (red) and HA-tagged PTPs Ig1–3 variants (green). Scale bar, 20mm. (c) Representative images from our cell-adhesion assays. One group of
L cells co-expressing DsRed and the indicated PTPs variants was mixed with a second group of L cells co-expressing EGFP and Slitrk1 (Slitrk1) or TrkC
(TrkC). Scale bar, 100mm (applies to all images). TrkC bound to all splice variants of PTPs, whereas Slitrk1 speciﬁcally interacted with PTPs variants
containing the splicing insert, MeB. (d–f) Bar graphs representing quantitative real-time RT–PCR results obtained from hippocampal neurons at the
indicated time points, measuring relative mRNA levels of total PTPs (d), the relative mRNA levels of PTPs variants containing MeB (e) and the proportion
of PTPs variants containing MeB (f). The data were normalized with respect to the values obtained at DIV5 (deﬁned as 1.0). Results are expressed as
means±s.d. (error bars) of three (n) independent experiments; statistical signiﬁcance (d–f) was assessed using analysis of variance with Tukey’s test.
Black bars are signiﬁcantly different compared with DIV5 groups (3*Po0.001).
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mVenus-fused Slitrk1 N162R and EGFP (Slitrk1 N162R), and
immunostained the neurons for the synaptic marker, synapsin.
We found that overexpression of Slitrk1 WT signiﬁcantly
increased the ﬂuorescence intensity and linear density of the
synapsin puncta on dendrites of transfected neurons, whereas
overexpression of the Slitrk1 N162R mutant did not (Fig. 3g,h).
These results suggest that Slitrk1 uses the same binding interfaces
in the A and B patches to induce presynaptic differentiation at
both excitatory and inhibitory synapses, and further indicate that
Slitrk1 promotes excitatory synapse development by directly
binding to PTPs in cultured hippocampal neurons.
Splicing insert MeB modulates LAR-RPTPs/Slitrk interaction.
The alternative splice variants in the Ig domains of the LAR-
RPTPs selectively modulate their binding afﬁnity to multiple
postsynaptic partners, including TrkC, IL-1RAcP and IL1RAPL1
(refs 7–9). The crystal structure of the PTPd Ig1–3/Slitrk1 LRR1
complex and our mutant analyses clearly demonstrated that an
arginine residue within MeB critically determines the interaction
between PTPs and Slitrk1 LRR1 (Figs 2 and 3). Structural
comparisons of PTPd Ig1–3 in the presence (current study) and
absence17 of MeB (PDB ID: 2YD9) revealed that the shortened
linker between Ig2 and Ig3 of PTPs Ig1–3 lacking MeB (PTPs
Ig1–3 MeAþ , MeB ) introduces a conﬂict between the Ig3
domain and Slitrk1 LRR1, even though the overall architecture of
the individual Ig domains and the V-shape of the rigid Ig1–Ig2
unit are well preserved (Fig. 4a and Supplementary Fig. 7).
Interestingly, the position of Ig3 in PTPd Ig1–3 (MeAþ , MeBþ )
was rotated about 62 around V225, which is the last residue in
the bG’ sheet of PTPd Ig2 (Fig. 4a, left). As shown in Fig. 3,
however, the C patch interaction is not critical for the binding
of Slitrk1 to LAR-RPTPs or the mediation of presynaptic
differentiation; thus, the signiﬁcance of this rotational shift is
not clear. Our structural analysis indicated that MeB contributes
to the binding of LAR-RPTPs to Slitrks by: (1) ﬁtting PTPd R229
(PTPs R238) directly into Arg pocket 2 on Slitrk1 LRR1; (2)
stabilizing the ﬂexible PTPd R226 (PTPs R235) into Arg pocket 1
on Slitrk1 LRR1; and (3) increasing the length of the linker
between Ig2 and Ig3 (Ig2–Ig3 linker), thereby relieving potential
steric hindrance between LAR-RPTPs and Slitrks (Fig. 4a, right).
Next, we tested whether the interactions between PTPs and Slitrk1
LRR1 are mainly regulated by the residues of MeB themselves or by
the longer Ig2–Ig3 linker in PTPs Ig1–3 (MeAþ , MeBþ ). To
mimic the short Ig2–Ig3 linker of PTPs Ig1–3 (MeAþ , MeB ),
we deleted the three residues (EVR) after R238 in PTPs Ig1–3
(MeAþ , MeBþ ) without changing the residues in MeB (blue box
in Supplementary Fig. 4) to create PTPs-DEVR. Intriguingly, cell
surface binding assays using HEK293T cells expressing various
PTPs Ig1–3 splice variants and PTPs-DEVR showed that
recombinant Slitrk1-Fc bound to PTPs-DEVR and a subset of
PTPs splice variants that contain MeB (that is, PTPs Ig1–3
(MeA , MeBþ ) and PTPs Ig1–3 (MeAþ , MeBþ ); Fig. 4b).
These results are consistent with those obtained from our cell-
adhesion assays (Fig. 4c), suggesting that the residues of the
splicing insert, MeB, are more crucial than the length of the Ig2–
Ig3 linker for the interaction with Slitrk1. To test this idea, we
carried out lentiviral knockdown (KD) of PTPs and rescue
experiments. Lentiviral-mediated PTPs KD in cultured
hippocampal neurons abolished the ability of Slitrk1 to cluster
VGLUT1, consistent with our previous report (Yim et al.10;
Supplementary Fig. 8e–g). Re-expression of full-length PTPs
(MeA , MeBþ ), but not full-length PTPs (MeA , MeB ),
completely restored the synaptogenic activity of Slitrk1, consistent
with our binding data (see Fig. 4). Moreover, the presence of MeB
in PTPd and LAR was also critical for Slitrk1 binding
(Supplementary Fig. 8a–d).
In the case of neurexins, which are highly polymorphic
owing to extensive alternative splicing18, the alternative splicing
events are frequently modulated by synaptic activity19.
To examine the temporal regulation of alternative splicing in
PTPs and PTPd during neuronal development, we used
quantitative reverse transcription–PCR (qRT–PCR) to monitor
the expression levels of the PTPs/d messenger RNA in cultured
rat hippocampal neurons. The mRNA levels of total PTPs/d and
the splicing isoform PTPs/d (MeBþ ), both sharply decreased
in cultured hippocampal neurons between DIV5 (days in vitro)
and DIV10, and remained consistent thereafter (Fig. 4d,e
and Supplementary Fig. 8h,i). Moreover, the proportion of
MeB-containing PTPs/d remained unchanged during postnatal
brain development (Fig. 4f and Supplementary Fig. 8j). These
data suggest that PTPs/d (MeBþ ) might be a dominant splice
variant of PTP s/d in the developing rat hippocampus, and that
the trans-synaptic complex containing LAR-RPTPs and Slitrks
might be important for initial synapse formation, rather than
late-stage synapse maturation.
Structural differences between Slitrk1 LRR1 and LRR2. To
examine the structural basis underlying the selective binding of
LAR-RPTPs to Slitrk LRR1, we performed a crystallographic
analysis of Slitrk1 LRR2 (Fig. 5, Supplementary Fig. 9d and
Table 1). As a model template for molecular replacement, we used
the variable lymphocyte receptor A, VLRA.R2.1, which has an
LRRNT, six LRR motifs and an LRRCT (PDB ID: 3M18)20. The
elution proﬁle obtained from size-exclusion chromatography
showed that Slitrk1 LRR2 existed in the monomeric form in the
solution. However, the asymmetrical unit of the Slitrk1 LRR2
crystal contained two identical (Ca root mean squared deviation:
0.61 Å) monomers arranged as a face-to-face dimer via their
concave surfaces. The overall structure of Slitrk1 LRR2 comprises
nine b-strands on the concave face and secondary-structure-free
loops on the convex surface. Slitrk1 LRR1 and LRR2 exhibit high
structural homology, with a Ca root mean squared deviation of
1.035Å. The loop connecting the anti-parallel strand in the
LRRNT of the Slitrk1 LRR2 domain was slightly different from
that in Slitrk1 LRR1 (Fig. 5a,c).
Sequence conservation analysis showed that the binding
interfaces of Slitrk1 LRR1 are highly conserved, whereas the
corresponding areas in Slitrk1 LRR2 are more variable
(Supplementary Fig. 9a). In addition, the charge distribution of
Slitrk1 LRR1 is precisely complementary to that of PTPd Ig1–3
over the binding interfaces, whereas the charges of Slitrk1 LRR2,
particularly in the area that corresponds to the A patch of Slitrk1
LRR1, conﬂict with those of PTPd Ig1–3 (Fig. 5b). We also
examined the electrostatic properties of other Slitrks, using model
structures generated by comparative homology modelling21, and
found that similar charge conﬂicts were present on the concave
surfaces of the LRR2 domains (Supplementary Fig. 9b).
The conserved residues, Y233 (A patch), R235 (B patch) and
R238 (B patch) in PTPs Ig1–3 (corresponding residues for PTPd
Ig1–3: Y224, R226 and R229, respectively) ﬁt into three distinct
pockets on the concave surface of Slitrk1 LRR1: the tyrosine (Tyr)
pocket in the A patch and arginine (Arg) pockets 1 and 2 in the B
patch, respectively (Fig. 5d, left panels). The Tyr pocket is formed
by R110, E133, Y134, E157 and V158 of Slitrk1; Arg pocket 1 is
formed by Q136, D138, N162, D183 and R185 of Slitrk1; and Arg
pocket 2 is formed by D163, R185, G186, E210 and D211 of
Slitrk1. A structural comparison of the Slitrk1 LRR1-binding
pockets with the corresponding areas in Slitrk1 LRR2 showed that
the conserved D138, V158 and G186 residues that contribute to
formation of the shallow pockets in Slitrk1 LRR1 are replaced by
amino acid residues with longer side chains (E455, I475 and
N503) in Slitrk1 LRR2, resulting in occlusion of the binding
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pockets. These structural differences in the binding pockets could
prevent LAR-RPTPs from binding to Slitrk1 LRR2 (Fig. 5d, right
panels). Taken together, these results suggest that unique
properties on the concave surface of Slitrk1 LRR1, such as the
binding pockets and complementary charge distributions, are key
determinants for the speciﬁc interaction of LAR-RPTPs with
Slitrk LRR1.
What, then, is the role of Slitrk LRR2? Among the many
LRR-containing neuronal proteins, the axon guidance molecule,
Slit, has four consecutive LRR domains in its extracellular region,
each of which executes a different role; for example, the D2
domain is responsible for the interaction with the ligand protein
Roundabout (Robo), while the D4 domain is responsible for Slit
dimerization22. Thus, we examined whether the LRR2 domain
induces dimerization of Slitrks in a manner similar to that of the
Slit D4 domain, or if it could regulate LAR-RPTPs/Slitrks
complex formation by masking the LAR-RPTPs-binding surface
on Slitrk LRR1. Negatively stained electron microscopic analysis
of recombinant Slitrk1 Full revealed that the relative positions of
Slitrk1 LRR1 and LRR2 are random, and the linker region
between Slitrk1 LRR1 and LRR2 is highly ﬂexible (Fig. 5e and
Supplementary Fig. 10). Individual Slitrk1 LRR1 and LRR2
90°
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Figure 5 | Structural comparison of Slitrk1 LRR1 and LRR2 domains. (a) Cartoon representation of the structure of Slitrk1 LRR2. The two views are
rotated by 90 along the horizontal axis. (b) Electrostatic potential of Slitrk1 LRR1, LRR2 and PTPd Ig1–3, as calculated by the Poisson–Boltzmann equation in
PyMOL. The structures are shown as open-book views and surface representations, with colour maps reﬂecting electrostatic properties (blue,
positively charged; red, negatively charged). The interfaces involved in electrostatic interactions are highlighted by dashed circles. (c) Superposition of
Slitrk1 LRR1 (dark blue) and Slitrk1 LRR2 (light blue), both depicted as ribbon diagrams. (d) The binding pockets for Y224 in PTPd (Y233 for PTPs; top),
R226 in PTPd (R235 for PTPs; middle) and R229 in PTPd (R238 for PTPs; bottom) within the A and B patches of LRR1 are shown as sticks and surfaces in
the left panel. Their corresponding positions in LRR2 are shown in the right panel. The PTPd residues that dock into the Slitrk1 pockets are represented
as coloured sticks (yellow for the Ig2 domain and magenta for the splicing insert, MeB). The residue numbers of PTPs are shown in parentheses.
(e) Representative negative-stained electron microscopy images of Slitrk1 Full ectodomain (yellow arrows indicate the horseshoe-shaped LRR domains).
The typical horseshoe-shaped structures and the randomness of the relative positions of each LRR domain can be observed from the two-dimensional
class averages displayed in the orange box. Among 1,403 particles, the percentile of particle numbers of each class are shown below each class
average. Scale bar, 10 nm.
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domains adopted curved conformations resembling horseshoes,
consistent with our crystal structures (marked with yellow arrows
in Fig. 5e). However, the LRR domains of Slitrk1 could not be
distinguished from each other in the low-resolution electron
microscopic image, owing to their structural similarity. In
addition, we did not observe intermolecular interactions for
dimerization, nor did we detect intramolecular interactions
between LRR1 and LRR2 of Slitrk1. Based on these results, we
speculate that Slitrk LRR2 might perform other functions, such as
binding to unidentiﬁed binding protein(s).
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(e) Representative cell surface binding assays. HEK293T cells expressing pDis-PTPs Ig1–3 were incubated with the indicated Slitrk1 LRR1-Fc variants and
analysed by immunoﬂuorescence imaging for Slitrk1 LRR1-Fc variants (red) and HA-tagged PTPs Ig1–3 (green). Scale bar ,20 mm. Representative
images (f,h) and quantiﬁcation (g,i) of the results from heterologous synapse-formation assays. HEK293T cells transfected with EGFP alone (Control) or
the indicated pDis-HA-Slitrk1 mutants (f,g) or pDis-Slitrk1 LRR1 mutants (h,i) were cocultured with hippocampal cultured neurons and immunostained
using antibodies against GFP/HA (green) and synapsin (red). ‘n’ in panels g and i denotes the total number of HEK293T cells analysed. In g: Control,
n¼ 19; WT, n¼ 18; D152R, n¼ 18, R72E/F74E, n¼ 15; and R72E/F74E/R143E, n¼ 19. In i: Control, n¼ 11; WT, n¼ 14; D152R, n¼ 15, R72E/F74E, n¼ 14; and
R72E/F74E/R143E, n¼ 16. Statistical signiﬁcance (g,i) was assessed using ANOVA with Tukey’s test (3*Po0.001). Scale bar, 30mm.
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Lateral clustering of PTPr/Slitrk1 complexes for synaptogenesis.
Previously, a hypothetical model was postulated wherein the
higher-order assemblies of the neurexin/neuroligin synaptic
adhesion complex are required for the presynaptic
differentiation activity of neuroligins23,24. In addition, functional
forward and reverse Eph/Ephrin synaptic adhesion signalling
requires formation of higher-order clusters, initiated by initial
contact between them in trans, followed by formation of
larger signalling clusters and ultimately leading to lateral
recruitment of additional Eph clusters25,26. Similar adhesion-
promoted lateral clustering has been reported for cadherins27.
Although an asymmetrical unit of the PTPd Ig1–3/Slitrk1
LRR1 complex crystal was found to contain only one molecule
of this complex, two discrete packing interactions along the
two-fold screw symmetrical axis were observed between adjacent
PTPd Ig1–3/Slitrk1 complexes in the crystal-packing lattice
(Fig. 6a). R72 and F74 on the convex surfaces of neighbouring
Slitrk1 LRR1 domains were found to interact with the
backbone of E279 from PTPd Ig1–3 via hydrophobic interactions
and hydrogen bonding, respectively. In addition, R143 on the
convex surface of neighbouring Slitrk1 LRR1 domains exhibited
weak charge interactions with E230 from PTPd Ig1–3, which is
located in MeB (Fig. 6b, left). The other packing interaction was
mainly mediated by hydrogen bonding between D152 of Slitrk1
LRR1 and R25 of the neighbouring PTPd Ig1–3 (Fig. 6b, right).
These lateral interaction interfaces, which were distinct from the
above-described binding interfaces (that is, the A and B patches;
see Fig. 2), could potentially contribute to the lateral clustering of
LAR-RPTP/Slitrk complexes at the synaptic junction.
To further investigate the potential biological signiﬁcance of
the lateral interactions observed in crystal packing, we performed
cell-adhesion assays, cell surface-binding assays and heterologous
synapse-formation assays with mutants designed to abolish the
lateral interactions. All of the designed Slitrk1 mutants (D152R,
R72E/F74E and R72E/F74E/F143E) appropriately folded and
shaped (Supplementary Fig. 11a,b), and maintained the binding
ability towards PTPs Ig1–3 (Fig. 6c–e; see also Supplementary
Fig. 11c for binding-afﬁnity data). Our heterologous synapse-
formation assays demonstrated that Slitrk1 R72E/F74E exhibited
signiﬁcantly decreased presynaptic differentiation activity than
Slitrk1 WT. Moreover, the addition of the R143E mutation to the
Slitrk1 R72E/F74E mutant completely abolished synaptogenic
activity. In contrast, the Slitrk1 D152R mutant did not show any
alteration of its synaptogenic activity (Fig. 6f,g). This conclusion
was also conﬁrmed using identical sets of Slitrk1 LRR1 constructs
(Fig. 6h,i), excluding any possible interaction of these mutant
proteins with the Slitrk1 LRR2 domain. Furthermore, to visualize
the dynamics of Slitrk1-induced PTPs clusters on the cell surface,
we transiently transfected COS-7 cells with full-length PTPs-
EGFP and examined live cells using time-lapse microscopy. Live-
cell imaging revealed that within 5min after treatment with
Slitrk1 LRR1-Fc, PTPs WT clusters formed at the cell surface,
clusters that may represent PTPs/Slitrk1 signalling cluster
(Fig. 7a,b; see also Supplementary Movies 1 and 2). Strikingly,
the addition of Slitrk1 R72E/F74E/F143E-Fc failed to induce the
formation of PTPs clusters (Fig. 7a,b and Supplementary Movies
1 and 2), although this Slitrk1 mutant properly binds to PTPs
(Fig. 6c,e). These data strongly support our proposed model that
both the binding of Slitrks to LAR-RPTPs and the subsequent
lateral clustering of this trans-adhesion complex are crucial for
presynaptic differentiation (Fig. 7c).
Discussion
LAR-RPTPs were originally identiﬁed as essential elements for
early neuron development, but they have recently emerged as
synaptic adhesion molecules2,3. Previous structural studies of
LAR-RPTPs focused on the Ig domains17,28 and catalytic
phosphatase domains29, and provided insights into the
arrangement of the Ig domains, the proteoglycan-mediated
clustering of the Ig domains and the role of the two tandem
phosphatase domains. From a structural perspective, however, we
do not yet understand the precise nature of the extracellular
interactions between LAR-RPTPs and multiple postsynaptic
adhesion molecules.
In the present study, we used structural, cell biological and
biochemical approaches to address the following major questions
left unanswered by previous studies: (1) How do Slitrks
speciﬁcally bind to LAR-RPTPs? (2) How is the LAR-RPTP/
Slitrk interaction regulated by alternative splicing of LAR-RPTPs?
(3) How do the speciﬁc actions of Slitrks and LAR-RPTPs specify
the formation of speciﬁc synapse types? To address these rather
challenging neuroscience questions, we turned to structural
biology in the hopes of identifying the molecular determinants
that are crucial for this interaction at an atomic level. This
structure–function study yielded four principal observations that
address most of the previously unanswered questions regarding
the LAR-RPTP/Slitrk synaptic adhesion complex.
First, LAR-RPTP Ig1–3 and Slitrk LRR1 constitute the minimal
binding regions for their mutual interaction (Fig. 1 and
Supplementary Figs. 1 and 2) and are sufﬁcient to mediate
their synaptogenic activity (Fig. 1 and Supplementary Fig. 1).
Our analysis of the crystal structure of this minimal binding
complex revealed that LAR-RPTP Ig2–Ig3 primarily binds to
the concave face of Slitrk1 LRR1, forming two crucial binding
regions, which we designated the A and B patches (Fig. 2).
Extensive functional assays conﬁrmed that a speciﬁc subset
of residues in the A and B patches are involved in both the
LAR-RPTP/Slitrk interaction and synaptogenic activity (Figs 2
and 3, and Supplementary Figs 5 and 6). Slitrk1 was previously
reported to promote excitatory synapse formation through
interactions with PTPs10. However, the results of our in vitro
biochemical assays as well as synapse-formation assays
unequivocally demonstrated that the Slitrk LRR1 domain binds
equally well to PTPd and PTPs, leading to inhibitory or
excitatory presynaptic differentiation, respectively. These
ﬁndings suggest that the endogenous localizations of various
Slitrk and/or LAR-RPTP isoforms, which are temporally and
spatially regulated during neuronal development, may determine
the speciﬁc type of synapse (either excitatory or inhibitory) that is
formed in vivo. We also postulate that unique cytoplasmic
complexes rather than extracellular protein interactions are
critical for driving development of distinct synapse types.
Additional studies will be required to elucidate the detailed
signalling pathways involved.
Second, the MeB splicing insert of LAR-RPTPs was found to
regulate the binding to Slitrks (Fig. 4). In cultured neurons and
rat brains, the expression level of total and MeB-positive PTPs
gradually decreased during postnatal development (Fig. 4),
whereas the total level of Slitrks steadily increased10. These data
suggest that the interaction of Slitrks with LAR-RPTPs may be
involved in initial synaptic speciﬁcation rather than late synaptic
maturation. The signiﬁcance of alternative splicing in the trans-
synaptic adhesion pathway has been extensively explored in the
case of the neurexin/neuroligin complex1,30,31. Similar to the case
of neurexins, the splicing inserts of LAR-RPTPs alter its binding
afﬁnity to various postsynaptic partners, such as TrkC, IL-1RAcP
and IL1RAPL1 (refs 2,3). Further systematic structural analyses of
LAR-RPTPs containing various splicing inserts, in complex with
diverse postsynaptic adhesion molecules, could unveil general and
complex molecular codes for the activation of selective synaptic
adhesion pathways.
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Third, we determined the structural elements that confer the
speciﬁc binding of LAR-RPTPs to Slitrk LRR1 (Fig. 5). LRR1 and
LRR2 are structurally very similar, but our analysis showed that
the shape of critical binding pockets and the distribution of
speciﬁc charged residues in LRR1 impart binding speciﬁcity.
Although further studies will be required to explore this issue, we
propose that Slitrk LRR2 may play yet unidentiﬁed roles, such as
interacting with other synaptic adhesion molecule. The interac-
tion of Slits with their ligands, the Robos, is comparable to that
between LAR-RPTPs and Slitrks, in that both interactions involve
the same structural motifs (LRR and Ig domains). In the Slit/
Robo interaction, the second LRR domain of Slit binds to the two
N-terminal Ig domains of Robo22. However, although the Slitrk/
LAR-RPTP and Slit/Robo interactions are mediated by common
structural motifs, the details of their binding mode appear to be
quite different. Speciﬁcally, a previous report showed that one
face of the b-strand in Robo Ig1 primarily participates in binding
to the concave face of the Slit LRR2 (ref. 22), whereas we herein
report for the ﬁrst time that the loop connecting Ig2 and Ig3 of
LAR-RPTP interacts with the concave face of Slitrk LRR1 (Fig. 4
and Supplementary Fig. 9c). These structural comparisons
indicate that many protein–protein interactions mediated by
the extracellular Ig and LRR domain32 have evolved to serve
divergent functions in the CNS through the speciﬁc binding of
distinct partners.
Fourth, we found that the lateral assembly between adjacent
PTPd Ig1–3/Slitrk1 complexes, which was observed in our
crystal-packing lattice, was critical for the synaptogenic activity
of Slitrks. Strikingly, Slitrk1 point mutants designed to abolish
these crystal-packing interactions impaired presynaptic differ-
entiation in our heterologous synapse-formation assays, but did
not affect the primary PTPd/Slitrk1 binding (Fig. 6), suggesting
that the binding of Slitrks to their presynaptic ligands is not
sufﬁcient to induce presynaptic differentiation. Although we
failed to observe multimeric PTPd/Slitrk1 complexes in solution,
the demonstration of Slitrk1-mediated clustering of PTPs/Slitrk1
complexes on the cell membrane by time-lapse microscopy
(Fig. 7) strongly suggests that the lateral assembly of these trans-
synaptic adhesion complexes is physiologically relevant and may
be crucial for efﬁcient propagation of downstream signals
required for proper presynaptic differentiation. Other postsynap-
tic partners of LAR-RPTPs could also synergistically and/or
cooperatively form a variety of trans/cis-synaptic adhesion
networks. A previous study has suggested that the catalytic
activity of LAR-RPTP most probably undergoes negative
regulation via dimerization (ligand-induced or otherwise)33.
Moreover, a prior study showed that heparan sulfate
proteoglycans induce the clustering of PTPs, thus facilitating
neuronal extension by unevenly distributing phosphatase activity
at the cell surface17. Although additional studies are needed to
further clarify the Slitrk-binding-induced conformational changes
and/or oligomerization of LAR-RPTPs, the higher-order
architecture initiated by the binding of Slitrks to LAR-RPTPs
could be a key event in the bidirectional neuronal signal
transduction. This could then lead to further synaptogenic
processes, as has been proposed for the higher-order
architecture of neurexin/neuroligin, cadherins, SynCAM1 and
Eph/Ephrin23–27,34,35.
Slitrk1 LRR1-Fc
WT
PT
Pσ
-
EG
FP
Slitrk1 LRR1-Fc
R72E/F74E/R143E
0 Min 5 Min
Two-step model of presynaptic development by LAR-RPTPs/Slitrks complex
5 Min0 Min
C C
LAR-RPTPs LAR-RPTPs
Time
2 Min 5 Min0
20
40
60
Δ 
N
um
be
r o
f c
lu
st
er
s/
ce
ll
80
100
120
Slitrk1 LRR1-Fc,
R72E/F74E/R143E
Slitrk1 LRR1-Fc, WT
Control (Fc alone)
3*
3*
N20 nm N
Direct
binding
Lateral
assembly
N N
C Slitrks Slitrks
Postsynaptic membrane
Lateral cluster
Presynaptic membrane
Induction of presynaptic differentiation
C
Figure 7 | Lateral clustering of PTPr/Slitrk1 complex induced by Slitrk1 binding. (a) Confocal time-lapse images of PTPs clustering in COS-7 cells
induced by addition of Slitrk1 WT-Fc, but not by Slitrk1 F72E/F74E/R143E-Fc (lateral-interaction mutant). Arrowheads indicate the representative clustering
events. Scale bar, 20mm. (b) Quantiﬁcation of data presented in a at each time point. Error bars represent s.d. from ﬁve different cells. Statistical
signiﬁcance was assessed using analysis of variance with Tukey’s test (3*Po0.001). (c) Model of the two-step presynaptic differentiation process
mediated by the binding of Slitrks to LAR-RPTPs and subsequent lateral assembly of trans-synaptic LAR-RPTPs/Slitrk complexes.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms6423
12 NATURE COMMUNICATIONS | 5:5423 | DOI: 10.1038/ncomms6423 | www.nature.com/naturecommunications
& 2014 Macmillan Publishers Limited. All rights reserved.
In conclusion, we herein used structural and functional studies
to probe the signiﬁcance of the interaction between LAR-RPTPs
and Slitrks during synapse formation, and provide a molecular
basis for the regulation of this interaction by alternative splicing
(particularly that involving the splicing insert, MeB). Moreover,
we dissected the process of Slitrk-induced presynaptic differentia-
tion into two molecular steps as follows: (1) the direct binding of
postsynaptic Slitrks to presynaptic LAR-RPTPs and (2) lateral
clustering mediated by the initially formed monomeric LAR-
RPTP/Slitrk trans-synaptic complexes (Fig. 7c). These rearrange-
ments of the extracellular architecture are likely to change the
catalytic activity of the intracellular phosphatase in LAR-RPTPs,
thereby inducing the recruitment of nascent presynaptic
machineries. Future studies should examine whether multimeric
LAR-RPTPs are catalytically active, how their multivalent binding
with multiple postsynaptic ligands can be modulated and how the
activations of downstream signalling pathways are speciﬁed.
Methods
Construction of expression vectors. All of the constructs used in this study are
summarized in Supplementary Table 1. MeA (ETFESTPIR for PTPs; ESIGGTPIR
for PTPd; GGSPIR for LAR) and/or MeB (ELRE for both PTPs and PTPd; DQRE
for LAR) were introduced into the pDis-PTPs Ig1–3 (MeA , MeB ) and pDis-
PTPd Ig1–3 (MeA , MeB ) construct to yield splice variants containing the
combination of MeA and MeB splicing inserts. We additionally generated pDis-
PTPs Ig1–3 DEVR, in which three amino acids (E239, V240 and R241) were
deleted from pDis-PTPs Ig1–3.
Recombinant expression and puriﬁcation. The ectodomain fragments of human
PTPd (aa 21E–322L) and PTPs (aa 30E–331L), which had been cloned into the
BamHI and XbaI sites of the pAcGP67 vector (BD Biosciences), were fused to the
protein A gene derived from pEZZ18 (GE Healthcare Life Sciences). The ectodo-
main fragment of Slitrk1 LRR1 (aa 20T–264K) or Slitrk1 LRR2 (aa 337N–580Q),
which had been cloned into the BamHI and NotI sites of the pAcGP67 vector (BD
Biosciences), were fused to the Fc domain of the human IgG gene (Supplementary
Table 1). A thrombin cleavage site (LVPRGS) was introduced between the target
and tagging genes. PTP ectodomain fragments (PTPd Ig1–3 and PTPs Ig1–3) and
Slitrk1 ectodomain fragments (Slitrk1 LRR1, Slitrk1 LRR2 and Slitrk1 Full) were
expressed in High Five insect cells (Invitrogen). High Five cells transfected with the
corresponding P4 baculovirus were incubated for 3 days and then pelleted by
centrifugation. The supernatants containing secreted proteins were pooled and
loaded onto IgG Sepharose columns (GE Healthcare Life Sciences) for the pur-
iﬁcation of the protein A-fused PTP ectodomain fragment, or protein A sepharose
columns (GE Healthcare Life Sciences) for puriﬁcation of the Slitrk1-Fc (Slitrk1
LRR1-Fc, Slitrk1 LRR2-Fc and Slitrk1 Full-Fc). The afﬁnity resin was washed
(50mM Tris-Cl, pH 8.0, and 200mM NaCl) and then treated with thrombin (0.5%
(v/v) in 20mM Tris-Cl, pH 8.0, and 200mM NaCl) at 4 C overnight to remove the
C-terminal protein A or Fc tags. The buffer was changed to 20mM MES, pH 6.5,
and cleaved proteins were loaded onto a cation-exchange HiTrap SP column (GE
Healthcare Life Sciences) and eluted with a 0–1M NaCl gradient. Fractions con-
taining recombinant proteins were further puriﬁed by gel-ﬁltration chromato-
graphy on a Superdex 200 column (GE Healthcare Life Sciences) equilibrated with
20mM Tris-Cl, pH 8.0, and 200mM NaCl, and then concentrated for crystal-
lization. The PTPd Ig1–3/Slitrk1 LRR1 complex was produced by mixing puriﬁed
Slitrk1 LRR1 (11mM in 840 ml) with PTPd Ig1–3 (63 mM in 120 ml) and incubating
the mixture for 3 h at 4 C. Thereafter, unbound Slitrk1 LRR1 was excluded by gel
ﬁltration chromatography (buffer: 20mM Tris-Cl, pH 8.0, and 200mM NaCl).
Fractions containing the PTPd Ig1–3/Slitrk1 LRR1 complex, which were forward
shifted in the chromatographic proﬁle, were pooled and further concentrated to
4mgml 1 for crystallization.
Pull-down assays. Slitrk1 LRR1-Fc, Slitrk1 LRR2-Fc, Slitrk1 Full-Fc and Fc alone
(20 mg) were individually incubated with 30 ml protein A sepharose (50% slurry; GE
Healthcare Life Sciences) at room temperature for 1 h. The beads were washed
three times with PBS and then incubated with 40 mg of PTPs Ig1–3 or PTPd Ig1–3
at room temperature for 1 h. The unbound proteins were removed by washing with
PBS and the resin-bound proteins were solubilized by boiling in 5 SDS–PAGE
sample buffer and analysed by 10% SDS–PAGE.
Cell-adhesion assays. Cell-adhesion assays were performed using L cells as
described previously36. Brieﬂy, two groups of L cells plated in six-well plates were
transfected individually with the expression vectors, as indicated. After 48 h, the
cells were trypsinized and resuspended in DMEM and the two groups of L cells
were mixed and rotated at room temperature to allow the cells to aggregate. The
extent of cell aggregation was measured after 2 h; aliquots were spotted onto four-
well culture slides and imaged by confocal microscopy. For quantiﬁcation of the
number of cells per cluster, cell clusters were deﬁned as cell aggregates that
contained four or more cells and included at least one green (EGFP) and one red
(DsRed) cell. Frames with no detectable cell clusters were counted as zero. The data
are presented as means±s.e.m. (n¼ 10–15 ﬁelds from at least three independent
experiments).
Heterologous synapse-formation assays. Heterologous synapse-formation
assays were performed using HEK293T cells, as described previously37. Brieﬂy, for
the experiments shown in Fig. 3d,e, HEK293T cells were transfected with EGFP
(negative control), pCMV5-Slitrk1-mVenus WT, or the various pCMV5-Slitrk1-
mVenus point mutants (described in the ‘List of point mutant plasmids generated
for this study’; see also Supplementary Table 3) using FuGene-6 (Roche). For the
experiments shown in Supplementary Fig. 6c, HEK293T cells were transfected with
EGFP, pDis-HA-Slitrk1 WT, or the various pDis-HA-Slitrk1 point mutants. After
48 h, HEK293T cells transfected with the indicated expression vectors, were
trypsinized, seeded onto hippocampal neuron cultures at DIV9, further cocultured
for 72 h and then (at DIV12) double-immunostained with antibodies against GFP
and synapsin I, VGLUT1 or VGAT36. All images were acquired with a confocal
microscope (LSM510, Zeiss). For quantiﬁcation, the contours of transfected
HEK293T cells were chosen as the region of interest. The ﬂuorescence intensity of
immunoreactive puncta were normalized with respect to each HEK293T cell area
and then quantiﬁed for both red and green channels using the MetaMorph
Software (Molecular Devices). The data are given as means±s.e.m. (n¼ 18–24
HEK293T cells; 3*Po0.001).
Afﬁnity measurement by solid-phase protein-binding assays. The afﬁnity of
Slitrk1 for LAR-RPTPs was determined using a solid-phase protein-binding assay.
Each variant (PTPd Ig1–3, PTPs Ig1–3) in PBS was immobilized on Maxi-Sorp 96-
well plates (NUNC; 1 mg per well) by incubating for 2 h at 37 C. Nonspeciﬁc
binding was blocked by incubating wells with 1% skim milk. After blocking, Fc-
fused Slitrk1 LRR1, LRR2 or LRR1þ LRR2 protein at different concentrations
(0.05, 0.1, 0.2, 0.3, 0.4, 0.5, 0.75, 1 and 2 mM) in 1% skim milk was added and plates
were incubated for 2 h at 37 C. After washing three times with PBS, horseradish
peroxidase-conjugated anti-human Fc antibody (1:10,000; Sigma) was added.
Immunoreactive proteins were detected by developing with TMB substrate (KPL)
for 5min. Thereafter, the reaction was quenched by the addition of 1M HCl and
absorbance was measured at 450 nm using a Model 680 microplate reader (Bio-
Rad). Absorbance values were plotted against Slitrk1 concentration and KD values
were determined by ﬁtting the curves to a one-site binding model by nonlinear
regression using GraphPad Prism 6.
Crystallization and structural determination. Crystals of PTPd Ig1–3/Slitrk1
LRR1 complex were grown for 1 week using the hanging-drop vapour-diffusion
method, in which 1 ml of protein complex (4mgml 1) was mixed with 1 ml of
crystallization buffer containing 100mM Tris-Cl, pH 8.5, 200mM ammonium
sulfate and 20% PEG3350 (v/v). Crystals of the PTPd Ig1–3/Slitrk1 LRR1 complex
belonged to space group P21 and had the following unit cell constants: a¼ 77.28 Å,
b¼ 60.37 Å, c¼ 84.14Å, a¼ 90.00, b¼ 102.14 and g¼ 90.00. For data collection
at 100 K, crystals were transferred to a cryoprotective solution containing 100mM
Tris-Cl, pH 8.5, 200mM ammonium sulfate, 23% PEG3350 (v/v) and 30% glycerol
(v/v), and shock frozen in liquid nitrogen. Crystals of Slitrk1 LRR2 were grown for
1 week using the hanging-drop vapour-diffusion method, in which 1 ml of protein
solution (1mgml 1) was mixed with 1 ml of crystallization buffer containing
100mM Na-citrate, pH 5.5, 16% isopropanol and 12% PEG4000 (v/v). Slitrk1
LRR2 protein crystals belonged to space group P6122 and had the following unit
cell constants: a¼ 69.70Å, b¼ 69.70Å, c¼ 410.20 Å, a¼ 90.00, b¼ 90.00 and
g¼ 120.00. For data collection at 100 K, crystals were transferred to a cryopro-
tective solution containing 100mM Na-citrate, pH 5.5, 16% isopropanol, 15%
PEG4000 (v/v) and 30% glycerol (v/v), and shock frozen in liquid nitrogen.
Diffraction data for crystals of Slitrk1 LRR2 and the PTPd Ig1–3/Slitrk1 LRR1
complex were collected at beamline 5.0.2 (Advanced Light Source) and 7A (Pohang
Accelerator Laboratory), respectively. The initial phases were calculated by the
molecular replacement technique using the PHASER programme38. The structure
of variable lymphocyte receptor A (PDB ID: 3M18)20, which has a six LRR motif,
was used as a search probe for the structure determination of Slitrk1 LRR2. The
reﬁned Slitrk1 LRR2 structure and the ﬁrst Ig domain of PTPd (PDB ID: 2YD6)17
were used as search models to determine the structure of the PTPd Ig1–3/Slitrk1
LRR1 complex, using the molecular replacement technique. The atomic models
were reﬁned by iterative rounds of model building performed using the Coot
programme39 and reﬁnements with CNS40, Refmac41 and PHENIX42 programmes.
The statistics for our data collection and reﬁnements are summarized in Table 1.
The quality of each model was checked using the PROCHECK analysis tool43.
Ramachandran plot analysis of the PTPd Ig1–3/Slitrk1 LRR1 complex structure
showed that 95.5%, 4.3% and 0.2% of residues were located in favoured regions,
allowed regions and outlier regions, respectively. The percentages of residues in the
Ramachandran favoured regions, allowed regions and outlier regions for the Slitrk1
LRR2 crystal structure were 95.2%, 4.8% and 0.0%, respectively.
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Antibodies. The following primary antibodies were used in this study: anti-
synapsin I (1 mgml 1, rabbit polyclonal; Millipore), anti-VGLUT1 (1 mgml 1,
guinea pig polyclonal; Millipore), anti-VGAT (1 mgml 1, rabbit polyclonal;
Synaptic Systems), anti-HA (1mgml 1, mouse monoclonal, clone HA-7; Covance)
and anti-EGFP (1 mgml 1, goat polyclonal; Rockland). The following secondary
antibodies were used: Cy3-conjugated anti-rabbit, Cy3-conjugated anti-guinea
(1mgml 1), ﬂuorescein isothiocyanate (FITC)-conjugated anti-goat (1 mgml 1),
FITC-conjugated anti-mouse (1mgml 1) and Cy5-conjugated anti-mouse
(1mgml 1) (all from Jackson ImmunoResearch).
Site-directed mutagenesis. The Slitrk1 and PTPs point mutants, described in
Supplementary Table 3 were generated with a QuickChange site-directed muta-
genesis kit (Stratagene) and veriﬁed by DNA sequencing. The PTPs and Slitrk1
residues are numbered with respect to the human PTPs (AAX50299.1) and Slitrk1
(NP_443142.1) sequence, respectively, which was previously described5,12.
Cell surface-binding assays. Slitrk1 LRR1-Fc (WT and point mutants;
Supplementary Tables 1 and 3) were produced from High Five insect cells as
described for the proteins that were used for crystallization. Recombinant Slitrk1
LRR1-Fc variants were puriﬁed with protein A-sepharose beads (GE Healthcare
Life Sciences). Instead of the thrombin cleavage step used for the puriﬁcation of the
crystallization proteins, the Slitrk1 LRR1-Fc variants were eluted with 100mM
glycine, pH 3.0, and immediately neutralized with 1M Tris-Cl, pH 8.0. Transfected
HEK293T cells expressing pDis-PTPs Ig1–3 point mutants (Y233S, R235A,
R238A, R235D/R238D, S248A or S248A/R295A) or EGFP (negative control) were
incubated with 0.2 mM Fc or Slitrk1 LRR1-Fc WT, as indicated in Fig. 3b. Trans-
fected HEK293T cells expressing pDis-PTPs Ig1–3 WT or DsRed (negative con-
trol) were incubated with 0.2 mM Fc, Slitrk1 LRR1-Fc WT or Slitrk1 LRR1-Fc
mutants (Y134R, 134W, 157A, I160W, N162R, D163R/D211R or Q248A) as
indicated in Fig. 3c. Images were acquired using a confocal microscope (LSM510;
Zeiss).
Primary neuron culture and immunocytochemistry. Rat hippocampal cultures
were prepared from E18 (embryonic day 18) embryos44. Brieﬂy, rat hippocampus
at E18 were dissected out, trypsinized and triturated to single-cell suspension.
These cells were cultured in neurobasal medium (Life Technologies). For
immunocytochemistry, cultured neurons were ﬁxed with 4% paraformaldehyde/4%
sucrose for 10min at room temperature, permeabilized with 0.2% Triton X-100 in
PBS for 5min at 4 C, blocked with 3% horse serum/0.1% crystalline grade BSA in
PBS for 30min at room temperature and sequentially incubated with the indicated
primary and secondary antibodies in blocking solution for 1 h at room
temperature. Transfected cells were randomly chosen and acquired using a
confocal microscope (LSM510; Zeiss) with a  63 objective lens; all image settings
were kept constant. Z-stack images obtained by confocal microscopy were
converted to maximal projections and analysed for intensity at the presynaptic
terminals using the MetaMorph software (Molecular Devices). All images were
separated by their colour channels (red and green), and red-coloured images were
transformed into grey-scale images using Photoshop (Adobe). All analyses were
performed in a blinded manner.
Biotinylation assays in HEK293T cells. HEK293T cells expressing pCMV5-
Slitrk1-mVenus WT or its point mutants were rinsed with PBS containing 1mM
MgCl2 and 1mM CaCl2, and then incubated with 1.0mgml 1 Sulfo-NHS-LC-
biotin (Thermo Scientiﬁc) in PBS for 30min at 4 C. The cells were rinsed in
100mM glycine in PBS to quench any unbound biotin, and then extracted in lysis
buffer (1% Triton X-100, 0.1% SDS) containing a complete protease inhibitor
cocktail (Roche). Biotinylated proteins were puriﬁed using NeutrAvidin agarose
(Pierce), separated by SDS–PAGE and analysed by western blotting with anti-
EGFP antibodies.
Surface labelling assays in HEK293T cells. Transfected HEK293T cells
expressing haemagglutinin-tagged Slitrk1 WT or the indicated Slitrk1 mutants
were incubated overnight at 4 C with 1 mgml 1 mouse anti-HA antibody in
DMEM containing 20mM HEPES, pH 7.4, and 0.1% BSA. The cells were then
washed with PBS, ﬁxed with 4% paraformaldehyde for 10min on ice, blocked with
3% skim milk in PBS for 30min at room temperature and incubated with anti-
mouse Cy3 antibodies (1:500 in blocking solution) for 1 h at room temperature.
Cells are then permeabilized with 0.2% Triton X-100 in PBS for 5min on ice,
washed and incubated with rabbit anti-HA antibody in DMEM containing 20mM
HEPES, pH 7.4, and 0.1% BSA for 1 h at room temperature to label intracellularly
endocytosed Slitrk1 proteins. Immunoreactive proteins were detected by incuba-
tion with FITC-conjugated anti-rabbit secondary antibodies (1:150 in blocking
solution). All experiments were repeated three times.
KD PTPr and rescue in hippocampal neurons. Recombinant lentiviruses were
produced by triply transfecting HEK293T cells with three plasmids—lentiviral
transfer vectors (L-309 alone, L-309 PTPs-KD, L-313 PTPs MeA /MeBþ , or
L-313 PTPsMeA /MeB ), psPAX and pMD2G—using FuGene-6 (Roche)10,45.
The psPAX and pMD2G plasmids encode the elements essential for packaging viral
particles. HEK293T cell supernatants were harvested 48 h post transfection and
puriﬁed46. Hippocampal neurons infected at DIV3 with control lentiviruses (sh-
Control) or shRNA targeting PTPs (sh-PTPs) or co-infected with lentiviruses
expressing PTPs shRNA plus the human shRNA-resistant PTPs splice variant
with an MeB insert (þPTPs MeBþ ), or PTPs shRNA plus the human shRNA-
resistant PTPs splice variant without an MeB insert (þPTPs MeB ). The
infected neurons were then cocultured for 2 days with HEK293T cells transfected
with EGFP alone (Control) or HA-Slitrk1 (Slitrk1), and stained with antibodies
against HA or EGFP (green) and VGLUT1 (red). KD efﬁcacy was measured using
qRT–PCR with primer set (50-GAA CCG ATA CGC CAA TGT CA-30 : forward
and 50-TCA CTA CCC ATG ATG CCT TCT AAA-30 : reverse).
qRT–PCR in cultured hippocampal neurons and rat brains. Rat cultured hip-
pocampal neurons plated on a 12-well plate were homogenized at DIV5, DIV10,
DIV15 and DIV20 in TRIzol Reagent (Invitrogen) and total RNA was extracted
according to the manufacturer’s protocol. The corresponding complementary DNA
was prepared from the total RNA by random priming using a cDNA synthesis kit
(Takara Bio). Quantitative real-time PCR was performed using a CFX96 Real-Time
PCR system (BioRad) and SYBR green reagents (Takara Bio). Primer sequences
were designed to detect MeB-containing splice variants of rat PTPs or rat PTPd.
The ubiquitously expressed mRNA, glyceraldehyde-3-phosphate dehydrogenase,
was detected as an endogenous control. RT–PCR values are presented as the ratio
of the signal obtained from the speciﬁc PTPs or PTPd splice variant versus that
from total PTPs or PTPd, respectively. The following primer pairs were used:
PTPs (MeBþ ), 50-GAG AGC TTC GAG AAG T-30 (forward) and 50-CTC TGC
CCC CTG CAT CCA CTT-30 (reverse); PTPd (MeBþ ), 50-TTC AGG TGT CAG
ATC TTC TGC-30 (forward) and 50-CTC GGC CCC CTG CAT CCA CTT-30
(reverse); PTPs (total), 50-GAG AGC TTC GAG AAG T-30 (forward) and 50-CTC
TGC CCC CTG CAT CCA CTT-30 (reverse); PTPd (total), 50-TTC AGG TGT
CAG ATC TTC TGC-30 (forward) and 50-CTC GGC CCC CTG CAT CCA CTT-30
(reverse); glyceraldehyde-3-phosphate dehydrogenase, 50-TGA TGA CAT CAA
GAA GGT GAA G-30 (forward) and 50-TCC TTG GAG GCC ATG TAG GCC AT-
30 (reverse). Total RNA was isolated from P1, P14 or P28 rat brains using the
TRIzol reagent and was used for cDNA synthesis. To examine the role of network
activity in regulating the expressions of PTPs, we treated cultured hippocampal
neurons at DIV5–10 with 20 mM NBQX, 50 mM D-APV, 25mM 4-aminopyridine
or 50 mM bicuculline for 72 h, or with 2 mM tetrodotoxin (all from Tocris
Bioscience) for 2 h.
Negative-stained TEM analysis and image processing. Slitrk1 Full (240 nM)
was applied to a glow-discharged carbon-coated 400 mesh copper grid (Electron
Microscopy Science), which was then stained with 0.75% uranyl formate solution
(Electron Microscopy Science)47. Images were acquired using a Tecnai T12 Bio-
TWIN transmission electron microscope equipped with an FEI Eagle 4 4K
charge-coupled device camera and operating at 120 kV. Particles (n¼ 1,403) for
Slitrk1 Full were manually selected from 100 micrographs using the EMAN2 boxer
programme48. The particles were subjected to three rounds of multivariate
statistical analysis classiﬁcation and multi-reference alignment using IMAGIC49.
Next, the 1,403 particles were grouped into six classes (B230 particles per class).
The class averages were sorted by the overall quality based on Representation
quality and Variance/Member analysed by IMAGIC. For the two-dimensional class
average of Slitrk1 LRR1 WT or mutants, B600 particles were selected from 30
micrographs and image processing were performed similarly as image processing
for Slitrk1 Full.
Live-cell imaging. COS-7 cells were cultured and transfected with a PTPs-EGFP
construct using Lipofectamine LTX (Invitrogen). After 12–18 h, the medium was
replaced with DPBS containing glucose (Invitrogen). Cells were treated with
10 mgml 1 of recombinant WT or lateral-interaction mutant (R72E/F74E/F143E)
Slitrk1 LRR1-Fc protein and imaged every 30 s for 7min with a confocal micro-
scope (Nikon A1) at  60 magniﬁcation. PTPs/Slitrk1 complex clusters were
detected by monitoring the ﬂuorescence of EGFP, C-terminally fused to PTPs.
MetaMorph Software (Molecular Devices) was used to assemble movies and
quantify Slitrk1-mediated surface clusters. For purposes of quantiﬁcation, clusters
were deﬁned as discrete puncta of ﬂuorescence that satisﬁed criteria of size (45
pixel) and circularity (0.1B1.0)50.
Circular dichroism. The secondary structures of puriﬁed SlitrK1 and its mutants
(R72E/F74E and R72E/F74E/R143E) are monitored by circular dichroism (CD) at
20 C in 1mm cell. The concentrations of SlitrK1 WT and its mutants (R72E/F74E
and R72E/F74E/R143E) for measurement are 53.9, 49.3 and 55.8 mM, respectively.
CD spectra were recorded using a Jasco J-815 CD spectrometer between 190 and
230 nm at 1-nm intervals averaged over 1 s. The molar ellipticity ([y]molar) is
calculated by equation described below.
y½ molar ¼ð100  yobsÞðd  mÞ degCm
2dmol 1
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where, yobs is the observed value of CD, d is distance of measuring cell and m is
molar concentration of the protein.
Statistics. All data are expressed as means±s.e.m. All experiments were per-
formed on at least three independent cultures and were evaluated statistically using
the Student’s t-test or the analysis of variance Tukey test, with the number of
experiments used as the basis for ‘n’ (*Po0.05, 2*Po0.01; 3*Po0.001).
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